The global carbon dioxide incubators market is expected to witness lucrative growth during the forecast period owing to an increasing number of applications of carbon dioxide incubators such as cancer research, embryonic cell research, stem cell research, neuroscience, tissue engineering, and cultivation of mammalian cells. Technological advancement and innovation in the carbon dioxide incubator devices such as password-protected settings, door opening alarms, auto decontamination cycles, self-calibration, pre-set alarms and over-temperature alarms and thermostats are expected to drive the demand for these devices over the forecast period.
In medical practice, incubators are used in order to grow and maintain cell culture or microbiological cultures. The incubators maintain humidity, temperature, and other conditions such as carbon dioxide (CO2) and oxygen content of the atmosphere inside. Incubators are essential for various experimental works in molecular biology and microbiology and in the culturing of both eukaryotic as well as bacterial cells. Carbon dioxide incubators are one of the most widely used incubators in any cell culturing laboratory environment.
The global carbon dioxide incubators market is segmented on the basis of product into non-insulated and insulated carbon dioxide incubators, water insulated and air jacket insulated carbon dioxide incubator, infrared controlled and HEPA enabled carbon dioxide incubators. Infrared controlled and HEPA enabled carbon dioxide incubators are expected to be fastest growing owing to the growing popularity and technological advancement in the infrared controlled and HEPA enabled carbon dioxide incubators thereby enhance the quality of results. Increasing innovations in energy efficiency, automation, and sensor technology, increasing government and corporate support for research & development, increasing awareness about advantages of carbon dioxide incubators among researchers, and increasing usage of next-generation equipment are expected to drive demand through the forecast period.
In 2014, North America accounted for the largest market share which is attributed to the increasing research and development activities in the life science and biotechnology sectors and manufacturers in the carbon dioxide market focusing on offering the products on the basis of the specific and unique requirements. Emerging economies such as Brazil, China, and India in the Asia Pacific region are expected to grow at a significant rate due to rising research and healthcare spending, increasing awareness about healthcare and personal care of the population and saturated markets in the developed countries.
The major participants in the global carbon dioxide incubators market include Panasonic Healthcare Co Ltd., Bellco Glass Inc., Thermo Fisher Scientific Inc., Eppendorf AG, NuAire Inc., Sheldon Manufacturing Inc., Memmert GmbH+CoKG, SP Industries Inc., and Binder GmbH. Thermo electron and Fisher scientific are gaining presence in the carbon dioxide incubators industry by merger and acquisition route. Thermo Electron entered the market by the acquisition of Thermo Forma.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.